Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cortex (Cor) [formerly CORX] -- Ignore unavailable to you. Want to Upgrade?

To: daveG who wrote (821)	6/9/1999 9:23:00 PM
From: JMarcus	Read Replies (2) \| Respond to of 1255

fyi, Harry Tracy (Neuroinvestment) posted the following today at ragingbull.com The momentum in this stock was based partially on a delayed response to genuinely positive developments (Organon, the Sz data, fiscal stability) and partially a premature and exaggerated anticipation of nearterm news. While an Alzheimer's deal is possible late in the year, the NIH AD data has not been fully analyzed as of yet--and even if encouraging--it would be several months of due diligence before anything could happen. That of course does not stop people from posting references to "Lilly would be a good match", as if one could not make equally valid (and misleading) references to several other companies. The notion that Organon was manipulating the stock price was even more absurd. This was a bounce that I did not think was going to happen until late in 99, and indeed it may well dissipate, given the short attention span of the Market nowadays. For those into Cortex for the long run, it is however true that its prospects have never been brighter--but they are not imminent. NeuroInvestment (www.neuroinvestment.com)